WAM
LUMO

Wealthspire Advisors (Maryland)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,111
Closed -$25K – 520
2019
Q4 		$25K Hold
1,111
– – ﹤0.01% 495
2019
Q3 		$16K Hold
1,111
– – ﹤0.01% 465
2019
Q2 		$15K Buy
+1,111
New +$16.8K ﹤0.01% 458

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
IFG
Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s LUMO Position: Q1 2020 in Review

Wealthspire Advisors (Maryland) sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 1,111 shares — an estimated $25K sold.

Wealthspire Advisors (Maryland) first reported a position in LUMO in Q2 2019 and held it in 3 quarters. The position peaked at $25K in Q4 2019. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

  • Wealthspire Advisors (Maryland) reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,111 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $25K.
  • Wealthspire Advisors (Maryland) first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
  • Wealthspire Advisors (Maryland)'s Lumos Pharma, Inc. Common Stock position peaked at $25K in Q4 2019.
  • 46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2020, filed 13 May 2020.